Data for: Resuscitative endovascular balloon occlusion of the aorta (REBOA) for temporization of hemorrhage in pediatric trauma patients.

Published: 26 April 2021| Version 1 | DOI: 10.17632/hb3g53jzh5.1
Alexis Smith


Background/Purpose: Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as an alternative technique for traumatic hemorrhagic shock control in the adult population. The purpose of this study is to describe the US experience with REBOA and further elucidate details of REBOA placement in pediatric trauma patients Methods: Patients 18 years of age or less who received REBOA for aortic occlusion (AO) from August 2013 to February 2017 at 2 urban tertiary care centers were included. Results: 7 adolescent trauma patients received REBOA by acute care surgeons for both blunt (n=4) and penetrating mechanisms (n=3); mean age was 17+1.5 years, mean admission lactate 13.0+4.85mmol/L, and mean Hgb 10.7+2.7g/dL. 3 patients received REBOA through a 12Fr sheath and 4 through a 7Fr sheath. AO occurred mostly at the distal thoracic aorta (Zone I) (85.7%), and also in the distal abdominal aorta (Zone III) (14.3%). 57% of patients were in arrest with ongoing CPR at the time of REBOA, and overall in-hospital mortality was 57%; all of these patients were in arrest at the time of REBOA with ongoing CPR, had return of spontaneous circulation (ROSC), and survived to the operating room. No complications from REBOA were identified. Conclusion: REBOA appears to be safe for use in adolescents despite their smaller caliber vessels, even with use of a 12Fr sheath. REBOA results in improved physiology and may bridge adolescent patients to the operating room, even those in arrest with ongoing CPR.



Clinical Outcomes Research